Literature DB >> 26427839

Dynamic Contrast-Enhanced MR Imaging in Head and Neck Cancer: Techniques and Clinical Applications.

S Gaddikeri1, R S Gaddikeri2, T Tailor1, Y Anzai3.   

Abstract

In the past decade, dynamic contrast-enhanced MR imaging has had an increasing role in assessing the microvascular characteristics of various tumors, including head and neck cancer. Dynamic contrast-enhanced MR imaging allows noninvasive assessment of permeability and blood flow, both important features of tumor hypoxia, which is a marker for treatment resistance for head and neck cancer. Dynamic contrast-enhanced MR imaging has the potential to identify early locoregional recurrence, differentiate metastatic lymph nodes from normal nodes, and predict tumor response to treatment and treatment monitoring in patients with head and neck cancer. Quantitative analysis is in its early stage and standardization and refinement of technique are essential. In this article, we review the techniques of dynamic contrast-enhanced MR imaging data acquisition, analytic methods, current limitations, and clinical applications in head and neck cancer.
© 2016 by American Journal of Neuroradiology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26427839      PMCID: PMC7960151          DOI: 10.3174/ajnr.A4458

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  75 in total

1.  Prediction of response to chemoradiation therapy in squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging.

Authors:  S Kim; L A Loevner; H Quon; A Kilger; E Sherman; G Weinstein; A Chalian; H Poptani
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-01       Impact factor: 3.825

2.  Optimization of the ultrafast Look-Locker echo-planar imaging T1 mapping sequence.

Authors:  A J Freeman; P A Gowland; P Mansfield
Journal:  Magn Reson Imaging       Date:  1998-09       Impact factor: 2.546

3.  Correlation of a priori DCE-MRI and (1)H-MRS data with molecular markers in neck nodal metastases: Initial analysis.

Authors:  Jacobus F A Jansen; Diane L Carlson; Yonggang Lu; Hilda E Stambuk; Andre L Moreira; Bhuvanesh Singh; Snehal G Patel; Dennis H Kraus; Richard J Wong; Ashok R Shaha; Jatin P Shah; Amita Shukla-Dave
Journal:  Oral Oncol       Date:  2012-02-25       Impact factor: 5.337

4.  Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PET.

Authors:  Jacobus F A Jansen; Heiko Schöder; Nancy Y Lee; Hilda E Stambuk; Ya Wang; Matthew G Fury; Snehal G Patel; David G Pfister; Jatin P Shah; Jason A Koutcher; Amita Shukla-Dave
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-01-13       Impact factor: 7.038

5.  Global cancer statistics.

Authors:  Ahmedin Jemal; Freddie Bray; Melissa M Center; Jacques Ferlay; Elizabeth Ward; David Forman
Journal:  CA Cancer J Clin       Date:  2011-02-04       Impact factor: 508.702

6.  The preoperative exclusion of thyroid carcinoma in multinodular goiter: Dynamic contrast-enhanced magnetic resonance imaging versus ultrasonography-guided fine-needle aspiration biopsy.

Authors:  Fatih Tunca; Y Giles; A Salmaslioglu; A Poyanli; D Yilmazbayhan; T Terzioglu; S Tezelman
Journal:  Surgery       Date:  2007-12       Impact factor: 3.982

7.  Dynamic Contrast Enhanced Magnetic Resonance Imaging in Oncology: Theory, Data Acquisition, Analysis, and Examples.

Authors:  Thomas E Yankeelov; John C Gore
Journal:  Curr Med Imaging Rev       Date:  2009-05-01

8.  Dynamic contrast-enhanced magnetic resonance imaging for estimating tumor proliferation and microvessel density of oral squamous cell carcinomas.

Authors:  Teruhisa Unetsubo; Hironobu Konouchi; Yoshinobu Yanagi; Jun Murakami; Masae Fujii; Hidenobu Matsuzaki; Miki Hisatomi; Hitoshi Nagatsuka; Jun-ichi Asaumi
Journal:  Oral Oncol       Date:  2008-11-21       Impact factor: 5.337

9.  Diagnostic value of dynamic contrast-enhanced MRI for submucosal palatal tumors.

Authors:  Hidenobu Matsuzaki; Yoshinobu Yanagi; Marina Hara; Naoki Katase; Miki Hisatomi; Teruhisa Unetsubo; Hironobu Konouchi; Toshihiko Takenobu; Hitoshi Nagatsuka; Jun-ichi Asaumi
Journal:  Eur J Radiol       Date:  2012-05-10       Impact factor: 3.528

Review 10.  Quantifying tumor vascular heterogeneity with dynamic contrast-enhanced magnetic resonance imaging: a review.

Authors:  Xiangyu Yang; Michael V Knopp
Journal:  J Biomed Biotechnol       Date:  2011-04-26
View more
  21 in total

Review 1.  Potential Role of PET/MRI for Imaging Metastatic Lymph Nodes in Head and Neck Cancer.

Authors:  Sungheon Gene Kim; Kent Friedman; Sohil Patel; Mari Hagiwara
Journal:  AJR Am J Roentgenol       Date:  2016-05-10       Impact factor: 3.959

Review 2.  Functional magnetic resonance imaging of head and neck cancer: Performance and potential.

Authors:  Ahmed H El Beltagi; Ahmed H Elsotouhy; Ahmed M Own; Wael Abdelfattah; Kavitha Nair; Surjith Vattoth
Journal:  Neuroradiol J       Date:  2018-11-06

3.  Tracking tumor radiotherapy response in vivo with Cherenkov-excited luminescence ink imaging.

Authors:  Jennifer A Soter; Ethan P M LaRochelle; Brook K Byrd; Irwin I Tendler; Jason R Gunn; Boyu Meng; Rendy R Strawbridge; Dennis J Wirth; Scott C Davis; David J Gladstone; Lesley A Jarvis; Brian W Pogue
Journal:  Phys Med Biol       Date:  2020-04-28       Impact factor: 3.609

4.  Magnetic resonance features of sinonasal melanotic mucosal melanoma.

Authors:  Cosimo Nardi; Chiara Vignoli; Margherita Vannucchi; Michele Pietragalla
Journal:  BMJ Case Rep       Date:  2019-07-22

5.  Prediction of Wound Failure in Patients with Head and Neck Cancer Treated with Free Flap Reconstruction: Utility of CT Perfusion and MR Perfusion in the Early Postoperative Period.

Authors:  Y Ota; A G Moore; M E Spector; K Casper; C Stucken; K Malloy; R Lobo; A Baba; A Srinivasan
Journal:  AJNR Am J Neuroradiol       Date:  2022-03-31       Impact factor: 3.825

6.  Differentiation of Skull Base Chondrosarcomas, Chordomas, and Metastases: Utility of DWI and Dynamic Contrast-Enhanced Perfusion MR Imaging.

Authors:  Y Ota; E Liao; A A Capizzano; A Baba; R Kurokawa; M Kurokawa; A Srinivasan
Journal:  AJNR Am J Neuroradiol       Date:  2022-08-11       Impact factor: 4.966

7.  Estimation of pharmacokinetic parameters from DCE-MRI by extracting long and short time-dependent features using an LSTM network.

Authors:  Jiaren Zou; James M Balter; Yue Cao
Journal:  Med Phys       Date:  2020-06-03       Impact factor: 4.071

8.  A prospective longitudinal assessment of MRI signal intensity kinetics of non-target muscles in patients with advanced stage oropharyngeal cancer in relationship to radiotherapy dose and post-treatment radiation-associated dysphagia: Preliminary findings from a randomized trial.

Authors: 
Journal:  Radiother Oncol       Date:  2018-09-08       Impact factor: 6.280

9.  Machine learning for semi-automated classification of glioblastoma, brain metastasis and central nervous system lymphoma using magnetic resonance advanced imaging.

Authors:  Nathaniel C Swinburne; Javin Schefflein; Yu Sakai; Eric Karl Oermann; Joseph J Titano; Iris Chen; Sayedhedayatollah Tadayon; Amit Aggarwal; Amish Doshi; Kambiz Nael
Journal:  Ann Transl Med       Date:  2019-06

10.  Application of integrated positron emission tomography/magnetic resonance imaging in evaluating the prognostic factors of head and neck squamous cell carcinoma with positron emission tomography, diffusion-weighted imaging, dynamic contrast enhancement and combined model.

Authors:  Haodan Dang; Yu Chen; Zhuhua Zhang; Xiaohua Shi; Xingming Chen; Xiaoli Zhu; Bo Hou; Haiqun Xing; Huadan Xue; Zhengyu Jin
Journal:  Dentomaxillofac Radiol       Date:  2020-04-03       Impact factor: 2.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.